Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Saori Uoyama"'
Autor:
Kumi Yoshida, Chiaki Ishii, Megumi Chiba, Yuichi Kurosaka, Saori Uoyama, Yukie Karibe, Saito Higuchi, Katsuko Fujikawa, Kazuki Hoshino
Publikováno v:
Journal of Infection and Chemotherapy. 20:312-316
DS-8587 is a novel broad-spectrum fluoroquinolone with extended antimicrobial activity against both Gram-positive and Gram-negative pathogens. In this study, we evaluated the in vitro and in vivo antibacterial activity of DS-8587 against multidrug-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f67fab018cd2b84c5342d4cdedfae66
https://doi.org/10.1016/j.jiac.2014.01.011
https://doi.org/10.1016/j.jiac.2014.01.011
Autor:
Saori Uoyama, Ryo Okumura, Saito Higuchi, Kazuki Hoshino, Kenji Namba, Yuichi Kurosaka, Yoshinori Kashimoto, Yoichi Murakami, Tsuyoshi Otani, Kazue Inoue
Publikováno v:
Antimicrobial Agents and Chemotherapy. 52:65-76
DC-159a is a new 8-methoxy fluoroquinolone that possesses a broad spectrum of antibacterial activity, with extended activity against gram-positive pathogens, especially streptococci and staphylococci from patients with community-acquired infections.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b279ab0274ecd218077e2e41567c684
https://doi.org/10.1128/aac.00853-07
https://doi.org/10.1128/aac.00853-07
Publikováno v:
The Japanese journal of antibiotics. 65(6)
An in vitro human plasma concentration simulation model with a hollow fiber system was established and used to evaluate the bactericidal effect of levofloxacin (LVFX) 500mg q.d. in combination with meropenem (MEPM) 1000mg t.i.d. against Pseudomonas a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fae5dda6b01c9399b29233c357bcc02
https://pubmed.ncbi.nlm.nih.gov/23593732
https://pubmed.ncbi.nlm.nih.gov/23593732
Autor:
Yoshinori, Kashimoto, Yuichi, Kurosaka, Yukie, Karibe, Saori, Uoyama, Katsuko, Fujikawa, Kenji, Namba, Tsuyoshi, Otani, Keizo, Yamaguchi
Publikováno v:
The Japanese journal of antibiotics. 62(5)
The in vitro and in vivo antibacterial activities of levofloxacin (LVFX), a quinolone antibacterial, against clinically isolated Legionella pneumophila were investigated in comparison with those of existing antimicrobial agents approved for legionnai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd3cb91fe44d6ac7219deefad571078b
https://pubmed.ncbi.nlm.nih.gov/20055122
https://pubmed.ncbi.nlm.nih.gov/20055122
Autor:
Yoshinori, Kashimoto, Yuichi, Kurosaka, Yukie, Karibe, Saori, Uoyama, Kenji, Namba, Tsuyoshi, Otani, Keizo, Yamaguchi
Publikováno v:
The Japanese journal of antibiotics. 62(5)
We present here a new model of Legionella pneumophila lung infection in DBA/2 mice. By intranasal inoculation with 106 colony-forming units of L. pneumophila strain suzuki serogoup 1, persistent non-lethal lung infection was established as reflected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1036933e4d99a35ce5aeb43f70a4cfe
https://pubmed.ncbi.nlm.nih.gov/20055121
https://pubmed.ncbi.nlm.nih.gov/20055121
Autor:
Saito Higuchi1 higuchi.saito.ir@daiichisankyo.co.jp, Yuichi Kurosaka1, Saori Uoyama1, Kumi Yoshida1, Megumi Chiba1, Chiaki Ishii1, Katsuko Fujikawa1, Yukie Karibe1, Kazuki Hoshino1
Publikováno v:
Journal of Infection & Chemotherapy (Elsevier Inc.). May2014, Vol. 20 Issue 5, p312-316. 5p.